C. P. Hans, D. D. Weisenburger, T. C. Greiner, R. D. Gascoyne, J. Delabie et al., Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray, Blood, vol.103, pp.275-82, 2004.

V. Bobée, P. Ruminy, V. Marchand, P. Viailly, A. Sater et al., Determination of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Reverse Transcriptase Multiplex Ligation-Dependent Probe Amplification Classifier, J Mol Diagnostics, vol.19, pp.892-904, 2017.

A. 'hern and R. P. , Sample size tables for exact single-stage phase II designs, Stat Med, vol.20, pp.859-866, 2001.

F. A. Morschhauser, G. Cartron, C. Thieblemont, P. Solal-céligny, C. Haioun et al.,

, Obinutuzumab (GA101) monotherapy in relapsed/refractory diffuse large b-cell lymphoma or mantle-cell lymphoma: Results from the phase II GAUGUIN study, J Clin Oncol, vol.31, pp.2912-2919, 2013.